August 5, 2020
Ideal for Cell and Gene Therapy and COVID-19 research, BioStore IIIv provides improved thermal stability for stored materials, risk mitigation advantages and processes which are documented and repeatable CHELMSFORD, Mass. – Brooks Life Sciences, a division of Brooks Automation, today announced the immediate availability of BioStore™ IIIv, an automated next-generation alternative to manual -80͒°C mechanical freezers. BioStore [...]
CN Bio makes key senior appointments to support international commercial development
August 5, 2020
Appointments include James Craven as Chief Commercial Officer and Brian Manning as US Head of Sales Cambridge, UK: CN Bio, a leading cell culture company that has developed single and multi-organ microphysiological systems (MPS) to improve the accuracy and efficiency of drug discovery, today announced the appointments of James Craven as Chief Commercial Officer and Dr. [...]
INTEGRA’s pipetting solutions streamline workflow for Radix BioSolutions
August 5, 2020
Contract research organization (CRO) Radix BioSolutions is using the entire span of INTEGRA pipetting products to streamline its workflows and increase reproducibility. Dr Kerry Oliver, President and CSO of Radix, explained: “Our services cover everything from quantifying biomarkers and reagent labeling services to the development and production of multiplexed assays, and we use INTEGRA products across our workflow.” Using a whole range of INTEGRA products offers [...]
Lexogen Appoints Stéphane Barges as New CEO
August 4, 2020
VIENNA -- Today Lexogen, the transcriptomics and next-generation sequencing company, announced that Stéphane Barges, PhD, MBA has been appointed as new Chief Executive Officer effective from September 1, 2020. Stéphane Barges of Lexogen Dr. Barges said "Lexogen is already a renowned company thanks to the quality of its very innovative products and of its customer support [...]
Thermo Fisher Scientific Confirms Offer to Acquire QIAGEN Shares Expires on August 10
August 4, 2020
WALTHAM, Mass. -- Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today confirmed that its offer to acquire all of QIAGEN's ordinary shares for an increased price of €43.00 per share in cash will expire at 24:00 hours (Frankfurt am Main local time) / 18:00 hours (New York local time) on [...]
August 4, 2020
Nacka, Sweden, August 4, 2020: Atlas Copco has acquired the technology and operating assets of iTrap. The iTrap is an ion trap mass spectrometer instrument capable of highly sensitive real time gas analysis. The instrument is used for diagnostics or process control in semiconductor process chambers. The business is located in Oberkochen, in southern Germany, [...]
August 4, 2020
SAN JOSE, Calif. -- Loop Genomics has come one step closer to replacing Sanger sequencing with NGS. Loop's new product enables massively parallel multiplexing of colonies and cloned DNA's into a single tube and sequencing them on NGS instruments, reducing the time and cost of sequencing cloned DNA. "The decades old practice of sequencing amplicons from colonies is still prohibitively [...]
Luminex Corporation Announces Departure of G. Walter Loewenbaum from Its Board of Directors
August 4, 2020
Long-time Chairman to retire AUSTIN, Texas -- Luminex Corporation (Nasdaq: LMNX) today announced the retirement of its Chairman, G. Walter Loewenbaum, from its Board of Directors ("Board") effective August 3, 2020. "On behalf of Luminex's shareholders and Board, I would like to thank Wally for his invaluable service and contributions to Luminex for over 25 years," said Nachum 'Homi' [...]
Proposed Acquisition and Placing to raise a minimum of £13 million
August 4, 2020
Manchester, UK: Yourgene Health plc (AIM: YGEN), the international molecular diagnostics group, today announces a proposed placing (the "Placing") of new ordinary shares of 0.1 pence each ("Ordinary Shares") in the capital of the Company (the "Placing Shares") at a price of 17 pence per share (the "Placing Price") to raise a minimum of £13 million. The [...]
August 4, 2020
HERCULES, Calif. –Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, announced that the The United States Court of Appeals for the Federal Circuit today affirmed that 10x Genomics willfully infringed U.S. Patent 8,889,083, exclusively licensed to Bio-Rad from the University of Chicago. The Appeals Court upheld [...]
